Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk

Frontiers in Neurology(2022)

引用 1|浏览3
暂无评分
关键词
LRRK2,kinase,selectivity,inhibitors,Parkinson's disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要